CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 97 filers reported holding CABALETTA BIO INC in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,566,792 | +241.7% | 300,052 | +85.7% | 0.00% | – |
| Q1 2023 | $1,336,399 | +18991.4% | 161,596 | +1369.6% | 0.00% | – |
| Q3 2022 | $7,000 | -53.3% | 10,996 | -21.1% | 0.00% | – |
| Q2 2022 | $15,000 | -46.4% | 13,945 | +0.6% | 0.00% | – |
| Q1 2022 | $28,000 | -44.0% | 13,859 | +5.2% | 0.00% | – |
| Q4 2021 | $50,000 | -90.4% | 13,174 | -69.3% | 0.00% | – |
| Q3 2021 | $522,000 | +71.7% | 42,967 | +21.5% | 0.00% | – |
| Q2 2021 | $304,000 | -39.0% | 35,373 | -21.2% | 0.00% | – |
| Q1 2021 | $498,000 | +26.7% | 44,887 | +42.6% | 0.00% | – |
| Q4 2020 | $393,000 | +44.5% | 31,480 | +25.6% | 0.00% | – |
| Q3 2020 | $272,000 | -14.7% | 25,069 | -12.3% | 0.00% | – |
| Q2 2020 | $319,000 | +72.4% | 28,600 | +13.0% | 0.00% | – |
| Q1 2020 | $185,000 | – | 25,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,454,627 | $20,299,765 | 16.92% |
| VR Adviser, LLC | 1,973,251 | $16,318,786 | 3.19% |
| COMMODORE CAPITAL LP | 1,835,000 | $15,175,450 | 2.31% |
| Velan Capital Investment Management LP | 250,000 | $2,067,500 | 1.76% |
| Cormorant Asset Management, LP | 1,821,739 | $15,066 | 0.99% |
| CAXTON CORP | 40,581 | $335,602 | 0.85% |
| TCG Crossover Management, LLC | 486,795 | $4,025,795 | 0.78% |
| Boxer Capital, LLC | 540,000 | $4,466 | 0.22% |
| FRED ALGER MANAGEMENT, LLC | 4,015,310 | $33,206,614 | 0.18% |
| Perceptive Advisors | 724,777 | $5,993,906 | 0.18% |